Alexey A. Matskevich
Directeur Technique/Scientifique/R&D chez TheraMAB LLC
Postes actifs de Alexey A. Matskevich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Alexey A. Matskevich
Anciens postes connus de Alexey A. Matskevich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01/01/2009 | 01/01/2009 |
| University of Zurich | Corporate Officer/Principal | 01/01/2008 | 01/01/2008 |
| University of Strasbourg | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
Formation de Alexey A. Matskevich
| Moscow State University Lomonosov | Doctorate Degree |
Statistiques
Internationale
| Russie | 3 |
| Suisse | 3 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
- Bourse
- Insiders
- Alexey A. Matskevich
- Expérience
